The response of cancer cells to hypoxia drives neo-angiogenesis but also enhances malignant phenotype development and an increased production of hypoxia-inducible factor (HIF-1), containing HIF-1α and HIF-1β subunits, that acts as a key regulatory transcription factor responsible for adaptive cellular changes. This evidence concerns the gene HIF1A and cancer.